ZA96448B - Tablet - Google Patents

Tablet

Info

Publication number
ZA96448B
ZA96448B ZA96448A ZA96448A ZA96448B ZA 96448 B ZA96448 B ZA 96448B ZA 96448 A ZA96448 A ZA 96448A ZA 96448 A ZA96448 A ZA 96448A ZA 96448 B ZA96448 B ZA 96448B
Authority
ZA
South Africa
Prior art keywords
tablet
Prior art date
Application number
ZA96448A
Other languages
English (en)
Inventor
Barry Howard Carter
Lloyd Gary Tillman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA96448(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA96448B publication Critical patent/ZA96448B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA96448A 1995-01-20 1996-01-19 Tablet ZA96448B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9501127.6A GB9501127D0 (en) 1995-01-20 1995-01-20 Tablet

Publications (1)

Publication Number Publication Date
ZA96448B true ZA96448B (en) 1996-08-07

Family

ID=10768317

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96448A ZA96448B (en) 1995-01-20 1996-01-19 Tablet

Country Status (39)

Country Link
US (1) US5879706A (ja)
EP (1) EP0806943B1 (ja)
JP (1) JP3350055B2 (ja)
KR (1) KR100412298B1 (ja)
CN (2) CN1131026C (ja)
AP (1) AP666A (ja)
AT (1) ATE190483T1 (ja)
AU (1) AU710823B2 (ja)
BG (1) BG63187B1 (ja)
BR (1) BR9606769A (ja)
CA (1) CA2210891C (ja)
CY (1) CY2182B1 (ja)
CZ (1) CZ296514B6 (ja)
DE (1) DE69607146T2 (ja)
DK (1) DK0806943T3 (ja)
EA (1) EA000276B1 (ja)
EE (1) EE03336B1 (ja)
ES (1) ES2145425T3 (ja)
FI (1) FI119722B (ja)
GB (1) GB9501127D0 (ja)
GE (1) GEP20022752B (ja)
GR (1) GR3033677T3 (ja)
HK (1) HK1002851A1 (ja)
HU (1) HU226131B1 (ja)
IL (1) IL116830A (ja)
IN (1) IN181318B (ja)
MY (1) MY126346A (ja)
NO (1) NO311488B1 (ja)
NZ (1) NZ298846A (ja)
OA (1) OA10500A (ja)
PL (1) PL185307B1 (ja)
PT (1) PT806943E (ja)
RO (1) RO118175B1 (ja)
SK (1) SK282030B6 (ja)
TR (1) TR199700657T1 (ja)
UA (1) UA68325C2 (ja)
UY (2) UY25774A1 (ja)
WO (1) WO1996022082A1 (ja)
ZA (1) ZA96448B (ja)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
DK0874631T3 (da) * 1996-01-19 2004-03-22 Glaxo Group Ltd Anvendelse af valaciclovir til fremstilling af et medikament til behandling af genital herpes ved en enkelt daglig anvendelse
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
PL356899A1 (en) * 1998-12-18 2004-07-12 Abbott Laboratories Controlled release formulation of divalproex sodium
GB0010446D0 (en) 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
OA12596A (en) * 2001-05-01 2006-06-08 Pfizer Prod Inc Method for manufacturing a low dose pharmaceuticalcomposition.
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
JP2005511612A (ja) * 2001-11-05 2005-04-28 グラクソ　グループ　リミテッド 塩酸バラシクロビルの無水結晶形
CA2649826A1 (en) * 2001-11-14 2003-05-22 Teva Pharmaceutical Industries Ltd. Synthesis and purification of valacyclovir
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20060147519A1 (en) * 2002-06-24 2006-07-06 Ashish Gogia Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
AU2003277433A1 (en) * 2002-10-16 2004-05-04 Teva Pharmaceutical Industries Ltd. Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
AU2003232719A1 (en) * 2003-05-30 2005-01-21 Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. Novel crystalline forms of valacyclovir hydrochloride
EP2014660A3 (en) * 2003-06-02 2009-07-15 Teva Pharmaceutical Industries Ltd Novel crystalline forms of valacyclovir hydrochloride
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
DK1663182T4 (da) 2003-09-12 2020-02-17 Amgen Inc Hurtigt opløsende formulering af cinacalcet HCI
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE60301277T2 (de) * 2003-12-09 2006-03-30 Helm Ag Pharmazeutische zubereitung enthaltend valaciclovir
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
KR101116747B1 (ko) 2004-12-06 2012-02-22 에스케이케미칼주식회사 안정성이 개선된 말레인산 암로디핀 약제 조성물
JP5304241B2 (ja) 2005-03-07 2013-10-02 バイエル・ヘルスケア・エルエルシー 癌の処置用のオメガ−カルボキシアリール置換ジフェニルウレアを含む医薬組成物
ATE546451T1 (de) * 2005-05-25 2012-03-15 Lilly Co Eli Cyclopropancarbonsäureester von acyclovir
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
WO2007090595A1 (en) * 2006-02-06 2007-08-16 Fidia Pharmaceutici S.P.A. Solid formulations of valacyclovir hydrochloride
JP2009536165A (ja) * 2006-05-10 2009-10-08 エボニック デグサ ゲーエムベーハー 医薬組成物におけるロール圧縮された熱分解的に製造された二酸化ケイ素の使用
ATE481089T1 (de) * 2006-05-31 2010-10-15 Vertex Pharma Orale formulierungen mit kontrollierter freisetzung eines interleukin-1-beta-converting- enzyme inhibitors
SI2040684T1 (sl) * 2006-07-11 2013-06-28 Lek Pharmaceuticals D.D. Večenotne tablete
US20080167325A1 (en) * 2006-12-27 2008-07-10 Bs Praveen Kumar Valacyclovir compositions
US20090076039A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched valacyclovir
ITRM20080027A1 (it) * 2008-01-18 2009-07-19 Maria Balestrieri Uso di aciclovir per il trattamento delle condilomatosi.
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
EP2407166B1 (en) * 2009-03-13 2013-08-21 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
CH703348A1 (de) * 2010-06-29 2011-12-30 Mepha Gmbh Zusammensetzungen mit hohem Wirkstoffanteil an pharmazeutisch aktiven Substanzen.
GB2515486A (en) * 2013-06-24 2014-12-31 Kraft Foods R & D Inc Soluble Beverage Ingredients
KR101497508B1 (ko) * 2013-12-20 2015-03-03 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2020049536A1 (en) * 2018-09-07 2020-03-12 Jubilant Generics Limited Pharmaceutical compositions of valacyclovir or its pharmaceutically acceptable salts thereof
CN110279667B (zh) * 2019-07-30 2023-02-10 珠海润都制药股份有限公司 一种盐酸伐昔洛韦片及其制备方法
JP2023551524A (ja) * 2020-12-01 2023-12-08 エルジー・ケム・リミテッド １－（３－シアノ－１－イソプロピル－インドール－５－イル）ピラゾール－４－カルボン酸を含む経口用製剤、およびその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
EP0349103B1 (en) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Chewable tablet
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet

Also Published As

Publication number Publication date
HUP9801872A2 (hu) 1999-10-28
AP9701057A0 (en) 1997-10-31
EE03336B1 (et) 2001-02-15
IL116830A (en) 2000-02-29
KR19980701524A (ko) 1998-05-15
EP0806943A1 (en) 1997-11-19
CN1313081C (zh) 2007-05-02
NO973327D0 (no) 1997-07-18
FI973062A0 (fi) 1997-07-18
CZ296514B6 (cs) 2006-03-15
HUP9801872A3 (en) 2001-02-28
NO973327L (no) 1997-09-16
CN1131026C (zh) 2003-12-17
SK282030B6 (sk) 2001-10-08
CN1494898A (zh) 2004-05-12
MX9705459A (es) 1997-10-31
JPH10512564A (ja) 1998-12-02
UY25778A1 (es) 2000-08-21
DE69607146T2 (de) 2000-09-21
KR100412298B1 (ko) 2004-04-21
HU226131B1 (en) 2008-05-28
UY25774A1 (es) 2000-10-31
UA68325C2 (en) 2004-08-16
BR9606769A (pt) 1997-12-30
WO1996022082A1 (en) 1996-07-25
FI973062A (fi) 1997-09-18
CA2210891C (en) 2009-05-19
US5879706A (en) 1999-03-09
IN181318B (ja) 1998-05-09
NO311488B1 (no) 2001-12-03
AP666A (en) 1998-08-24
MY126346A (en) 2006-09-29
GB9501127D0 (en) 1995-03-08
RO118175B1 (ro) 2003-03-28
EP0806943B1 (en) 2000-03-15
ATE190483T1 (de) 2000-04-15
GR3033677T3 (en) 2000-10-31
ES2145425T3 (es) 2000-07-01
PL321361A1 (en) 1997-12-08
DE69607146D1 (de) 2000-04-20
AU4453496A (en) 1996-08-07
OA10500A (en) 2002-04-10
FI119722B (fi) 2009-02-27
IL116830A0 (en) 1996-05-14
PT806943E (pt) 2000-08-31
HK1002851A1 (en) 1998-09-25
NZ298846A (en) 1998-06-26
CN1179100A (zh) 1998-04-15
JP3350055B2 (ja) 2002-11-25
SK96497A3 (en) 1998-01-14
GEP20022752B (en) 2002-08-26
CZ229297A3 (cs) 1998-02-18
BG101831A (en) 1998-04-30
PL185307B1 (pl) 2003-04-30
EA000276B1 (ru) 1999-02-25
EA199700123A1 (ru) 1997-12-30
TR199700657T1 (xx) 1998-02-21
CY2182B1 (en) 2002-08-23
AU710823B2 (en) 1999-09-30
CA2210891A1 (en) 1996-07-25
BG63187B1 (bg) 2001-06-29
DK0806943T3 (da) 2000-07-24

Similar Documents

Publication Publication Date Title
GB9501127D0 (en) Tablet
IL123614A0 (en) Chewable tablet
AU132520S (en) Tablet
EP0852208A4 (en) TABLET CONTAINER
AU128017S (en) Pharmaceutical tablet
GB9509388D0 (en) Hsbwls
GB9518465D0 (en) Pharmaceuticals
AU129056S (en) Pharmaceutical tablet
AU133610S (en) Tablet
AP9600802A0 (en) Libricant
CA77348S (en) Tablet
GB9525706D0 (en) Tablet dispencer
CA76097S (en) Can
AU1105P (en) DALESE Metrosideros excelsus
GB9506170D0 (en) Pharmaceuticals
GB9513768D0 (en) Pharmaceuticals
GB9513208D0 (en) Pharmaceuticals
GB9513207D0 (en) Pharmaceuticals
GB9511993D0 (en) Pharmaceuticals
GB9511850D0 (en) Pharmaceuticals
GB9520678D0 (en) Pharmaceuticals
GB9507708D0 (en) Pharmaceuticals
GB9506663D0 (en) Pharmaceuticals
GB9513210D0 (en) Pharmaceuticals
GB9505548D0 (en) Pharmaceuticals